基于网络药理学探讨银杏叶治疗阿尔茨海默病的潜在作用机制

doi:10.19803/j.1672-8629.2022.09.08

中国药物警戒 ›› 2022, Vol. 19 ›› Issue (9): 967-972.
DOI: 10.19803/j.1672-8629.2022.09.08

基于网络药理学探讨银杏叶治疗阿尔茨海默病的潜在作用机制

李媛媛¹, 刘胜伟², 任忠洋³, 丁玲⁴, 刘洁^4,*, 廖原⁵

¹张家口市沙岭子医院,河北张家口 075100;
²重庆医科大学附属永川医院,重庆 402160;
³重庆市江津区中医院,重庆 402284;
⁴重庆市江津区中心医院,重庆 402260;
⁵杭州师范大学生命与环境科学学院,杭州 310036

收稿日期:2021-03-16 出版日期:2022-09-15 发布日期:2022-09-16
通讯作者: ^*刘洁,女,硕士,主管药师,中药药理与神经药理学。E-mail：453039683@qq.com
作者简介:李媛媛,女,本科,主治医师,精神科与临床医学。
基金资助:
国家自然科学基金资助项目（31701189）; 重庆市科卫联合中医药技术创新与应用发展项目（2021ZY3591）; 重庆医科大学附属永川医院资助项目（YJJC202009）

Potential mechanism of Ginkgo biloba in the treatment of Alzheimer's disease based on network pharmacology

LI Yuanyuan¹, LIU Shengwei², REN Zhongyang³, DING Ling⁴, LIU Jie^4,*, LIAO Yuan⁵

¹Shalingzi Hospital of Zhangjiakou City, Zhangjiakou Hebei 075100;
²Yongchuan Hospital of Chongqing Medical University, Chongqing 402160, China;
³Jiangjin Hospital of Traditional Chinese Medicine,Chongqing 402284, China;
⁴Jiangjin Central Hospital of Chongqing,Chongqing 402260, China;
⁵College of Life and Environmental Sciences, Hangzhou Normal University,Hangzhou, Zhejiang,310036

Received:2021-03-16 Online:2022-09-15 Published:2022-09-16

摘要/Abstract

摘要： 目的利用网络药理学方法,探讨银杏叶治疗阿尔茨海默病(Alzheimer’s disease,AD)的潜在机制。方法通过中药系统药理学数据库和分析平台（TCMSP）,筛选银杏叶高度活性化学成分,预测潜在靶点;通过GeneCards、OMIM、CTD、TTD和Drugbank数据库检索AD相关靶点。通过Uniprot数据库转换活性成分潜在靶点并与AD相关靶点取交集,得到银杏叶抗AD的相关靶点。利用STRING11.0数据库构建靶蛋白相互作用网络图,筛选关键基因,并通过软件Cytoscape 3.8.2中的“Clue GO”插件,对银杏叶治疗AD的作用靶点进行GO功能富集分析及KEGG信号通路分析。结果共检测到银杏叶有效化学成分32种,有效成分靶标144个;AD相关靶点470个;取交集后获得银杏叶治疗AD的潜在靶点51个。活性成分β-谷甾醇、豆甾醇、邻苯二甲酸二丁酯等主要作用于ALB、PTGS2、ESR1、BCL-2等关键靶点,通过GABA能突触信号通路、钙信号通路、PI3K-Akt信号通路等发挥抗炎、抗氧化、抗凋亡、活血通络等功能治疗AD。结论利用中药“多成分-多靶点-多通路”的特点,探究银杏叶治疗AD的潜在作用机制,为银杏叶治疗AD以至扩大适应证的后续科学研究和临床应用提供一定基础。

关键词: 银杏叶, 阿尔茨海默病, 网络药理学, β-谷甾醇, 豆甾醇, 邻苯二甲酸二丁酯

Abstract: Objective To explore the potential mechanism of Ginkgo biloba against Alzheimer’s disease (AD) using the network pharmacology method. Methods Via the Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP), highly active chemical components of Ginkgo biloba were screened to predict potential targets. GeneCards, OMIM, CTD, TTD and Drugbank databases were searched for AD-related targets. Based on the Uniprot database, the potential targets of the active ingredients were converted while AD-related targets were crossed to obtain the AD-related targets of Ginkgo biloba. The STRING11.0 database was used to construct the target protein interaction network diagram. The key genes were screened, and the “Clue GO” plug-in in the software Cytoscape 3.8.2 was used for GO function enrichment analysis and KEGG signal pathway analysis of AD-related targets. Results A total of 32 effective chemical constituents of Ginkgo biloba leaves, 144 effective constituent targets, 470 AD-related targets, and 51 potential targets of Ginkgo biloba against AD were detected. Such active ingredients as β-sitosterol, stigmasterol and dibutyl phthalate mainly acted on such key targets as ALB, PTGS2, ESR1and BCL-2 by exerting anti-inflammatory, anti-oxidation and anti-apoptosis effects or by activating blood through the GABA synaptic signaling pathway, calcium signaling pathway or PI3K-Akt signaling pathway. Conclusion Based on the multi-component, multi-target and multi-pathway properties of traditional Chinese medicine, the potential mechanism of Ginkgo biloba against Alzheimer’s disease has been explored, which is expected to facilitate research on clinical application of Ginkgo biloba in the treatment of Alzheimer’s disease.

Key words: Ginkgo biloba, Alzheimer's disease, network pharmacology, β-sitosterol, stigmasterol, dibutyl phthalate

中图分类号:

R965.1

李媛媛, 刘胜伟, 任忠洋, 丁玲, 刘洁, 廖原. 基于网络药理学探讨银杏叶治疗阿尔茨海默病的潜在作用机制[J]. 中国药物警戒, 2022, 19(9): 967-972.

LI Yuanyuan, LIU Shengwei, REN Zhongyang, DING Ling, LIU Jie, LIAO Yuan. Potential mechanism of Ginkgo biloba in the treatment of Alzheimer's disease based on network pharmacology[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 967-972.

参考文献

[1] ZI WL, LI PC, XIAO XL, et al.Meta-analysis of ginkgo biloba preparation for the treatment of Alzheimer’s disease[J]. Clinical Neuropharmacology, 2020, 43(4): 93-99.
[2] CLAY E, ZHOU J, YI ZM, et al.Economic burden for Alzheimer’s disease in China from 2010 to 2050: a modelling study[J].Journal of Market Access & Health Policy, 2019, 7(1):1667195-1667201.
[3] YIN H, LIU GZ.Research progress of ginkgo biloba extract in the treatment of Alzheimer’s disease[J]. Chinese Medicine(中国医药), 2020, 15(1):151-152.
[4] LIU J, PEI M, ZHENG C, et al.A systems-pharmacology analysis of herbal medicines used in health improvement treatment: predicting potential new drugs and targets[J]. Evid Based Complement Alternat Med, 2013(6): 938764-938769.
[5] XIA L, GU S, QIAN DW, et al.To study the potential mechanism of Bazhen Yizhi Decoction in the treatment of Alzheimer’s disease based on network pharmacology and molecular docking technology[J]. Journal of Nanjing University of Traditional Chinese Medicine(南京中医药大学学报), 2020(6): 100-105.
[6] ISMAIL Z, BLACK S E, CAMICIOLI R, et al.Recommendations of the 5th Canadian consensus conference on the diagnosis and treatment of dementia[J]. Alzheimer’s & Dementia, 2020, 16(8): 24-33.
[7] CHENG XL, ZHANG XL, WU XP, et al. Effect of aripiprazole on metabolism of patients with senile dementia and mental disorder and correlation between therapeutic effect and blood drug concentration[J/OL]. [2021-02-03].Chinese Journal of Pharmacovigilance.https://kns.cnki.net/kcms/detail/11.5219.R.20210202.1456.056.html.
[8] YANG SB, PEI CC, SHI W, et al.Study on network pharmacology of Guizhi Fuling prescription[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(4): 214-220.
[9] WANG Y, ZHAN T.Aggravation of Alzheimer’s disease due to the COX-2-mediated reciprocal regulation of IL-1 beta and A beta between glial and neuron cells[J]. Aging Cell, 2014, 24(3): 256-261.
[10] XU SJ, ZHAO YJ, ZHANG WS.The pathogenesis of mild cognitive impairment from the evolution of cerebral collateral function in Traditional Chinese medicine[J]. Journal of Traditional Chinese Medicine(中医杂志), 2011, 52(19): 1627-1629.
[11] LIU WL, JI L, HUANG AX.Research and development progress of β-sitosterol[J]. Farm Products Processing(农产品加工), 2019(1): 77-79, 82.
[12] VALERIO M, AWAD AB.β-sitosterol down -regulates some pro-inflammatory signal transduction pathways by increasing the activity of tyrosine phosphatase SHP -1 in J774A.1 murine macrophages[J].International Immunopharmacology, 2011, 16(8): 1012-1017.
[13] CHOI JN, CHOI YH, LEE JM, et al.Anti-inflammatory effects of β-sitosterol-β-D-glucoside from trachelospermum jasminoides(Apocynaceae)in lipopolysaccharide-stimulated RAW 264.7 murine macrophages[J].Natural Product Research, 2012, 26(24): 2340-2343.
[14] LEE SE, LEE Y, LEE GH.The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain[J]. Arch Pharm Res, 2019, 42(12): 1031-1039.
[15] PAPAZIAN I, KYRARGYRI V, EVANGELIDOU M, et al.Mesenchymal stem cell protection of neurons against glutamate excitotoxicity involves reduction of NMDA-triggered calcium responses and surface GluR1, and is partly mediated by TNF[J]. Int J Mol Sci, 2018, 19(3): 651-657.
[16] WANG S, SHUN Y, LI CM, et al.Review on research progress of stigmasterol[J]. The Herb Depot(中国药业), 2019, 28(23): 96-98.
[17] ZHU CZ, XIONG HY, LI YP, et al.Regulation of gene expression in PC12 neurons induced by dibutyl phthalate as a plasticizer[J]. Chinese Journal of Neuromedicine(中华神经医学杂志), 2007, 6(9): 903-908.
[18] KHACHATURIAN ZS.Calcium, membranes, aging, and Alzheimer’s disease. Introduction and overview[J]. Ann NY Acad Sci, 1989, 1989(568): 1-4.
[19] DAY DH.Alzheimer’s disease: a short introduction to the calmodulin hypothesis[J]. AIMS Neuroence, 2019, 6(4): 231-239.
[20] DEMURO A, PARKER I, Stutzmann GE.Calcium signaling and amyloid toxicity in Alzheimer disease[J]. J Biol Chem, 2010, 285(17): 12463-12468.
[21] POPUGAEVA E, PCHITSKAYA E, BEZPROZVANNy I.Dysregulation of neuronal calcium homeostasis in Alzheimer’s disease-a therapetic opportunity?[J]. Biochem Biophys Res Commun, 2017, 483(4): 998-1004.
[22] XU BC, TU JM, LIU J, et al.Clinical analysis of the effect of hypoalbuminemia on complications in hospitalized senile dementia patients[J]. Medical Frontier(医药前沿), 2013, 11(3): 96-97.
[23] HU YM, WANG HY, QIN LJ.Protective effect of compound ginkgo leaf granules on liver function damage in acute pancreatitis[J].Chinese Pharmacy(中国药房), 2017, 28(11): 1538-1541.
[24] XIAO RC, XIU LC, YUE Z, et al.Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer’s disease animal model[J].Frontiers in Aging Neuroscience, 2013, 2013(5):65-71.
[25] Danira TR, Diana FB, Oscar RC, et al.Evaluation of inflammation-related genes polymorphisms in Mexican with Alzheimer’s disease: a pilot study[J]. Frontiers in Cellular Neuroence, 2015, 2015(9): 148-155.
[26] GUO JW, GUAN PP, DING WY, et al.Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer’s disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice[J]. Biomaterials, 2017, 2017(145): 106-127.
[27] XIONG MJ, CHEN GJ.Advances in studies on the effect of estrogen on cognitive function improvement in Alzheimer’s disease[J].Chongqing Medicine(重庆医学), 2014, 43(28): 3807-3810.

基于网络药理学探讨银杏叶治疗阿尔茨海默病的潜在作用机制

Potential mechanism of Ginkgo biloba in the treatment of Alzheimer's disease based on network pharmacology

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	杨珍珍, 常成, 高娜, 张晓林, 宋银森, 刘颖, 范天黎. 基于网络药理学和体外研究探讨木犀草素抑制食管鳞状细胞癌的分子机制[J]. 中国药物警戒, 2023, 20(9): 992-1001.
[2]	殷玉玲, 胡楚涓, 张晓朦, 王雨, 张冰, 林志健. 菊苣提取物抗阿霉素心脏毒性作用挖掘及验证[J]. 中国药物警戒, 2023, 20(8): 858-865.
[3]	梅雨, 朱越, 张慧婷, 肖成荣, 高月, 马增春. 基于网络药理学和实验验证探讨中药复方CB001对低剂量辐射防护的作用机制[J]. 中国药物警戒, 2023, 20(8): 872-879.
[4]	苏月芬, 郑婧柔, 宫贺, 谢广通, 张洁, 赛春梅. 乳腺结重痛轻凝胶贴膏的成型性及治疗乳腺增生作用机制研究[J]. 中国药物警戒, 2023, 20(7): 783-790.
[5]	陈梦苹, 王雅欣, 姚荣妹, 包蕾, 赵荣华, 孙静, 耿子涵, 鲍岩岩, 戴敏, 郭姗姗, 崔晓兰. 基于网络药理学及实验验证探究清开灵软胶囊治疗冠状病毒肺炎的作用机制[J]. 中国药物警戒, 2023, 20(3): 253-257.
[6]	李舒冉, 郭姗姗, 崔晓兰. 单纯疱疹病毒I型与阿尔茨海默病相关性及中药抗单纯疱疹病毒I型感染研究进展[J]. 中国药物警戒, 2023, 20(3): 258-261.
[7]	付昌丽, 陆苑, 陈思颖, 王永林, 李勇军, 王爱民, 刘春花. 红禾麻入血成分治疗类风湿性关节炎的作用机制[J]. 中国药物警戒, 2023, 20(2): 171-176.
[8]	王晓慧, 张帆, 夏文彬, 魏玉辉. 基于网络药理学和转录组学探讨京尼平致肝毒性机制[J]. 中国药物警戒, 2023, 20(2): 177-180.
[9]	曹琳, 冉峥, 侯强, 邱作成, 杨建华. 化铁丸化学成分分析及其防治乳腺增生的潜在机制预测[J]. 中国药物警戒, 2023, 20(10): 1113-1120.
[10]	王如梦, 郭梓琪, 杨宏新, 杨勇. 基于网络药理学及分子对接探讨荜茇治疗胃癌的作用机制研究[J]. 中国药物警戒, 2023, 20(10): 1121-1128.
[11]	吴作敏, 杨娟, 王隆隆, 王瑞. 黄芪-防风药对治疗新型冠状病毒肺炎的网络药理学研究[J]. 中国药物警戒, 2022, 19(4): 395-399.
[12]	刘晓莉, 刘胜伟, 廖原, 曾凡平, 刘洁. 石斛碱抗脑缺血再灌注损伤的网络药理学研究[J]. 中国药物警戒, 2022, 19(3): 252-258.
[13]	张强, 杜鹏程, 满春蕊, 孙倩. 银杏叶治疗心绞痛的网络药理学研究[J]. 中国药物警戒, 2022, 19(2): 158-163.
[14]	石强, 刘胜伟, 沈正泽, 陈昶, 任忠洋, 刘洁, 胡毅. 贝沙罗汀抗脑缺血再灌注损伤的网络药理学研究[J]. 中国药物警戒, 2022, 19(12): 1332-1337.
[15]	白思宇, 陈倩雯, 叶潇, 冯伟红, 荣立新, 李春. 藏药榜嘎抗流感的网络药理学分析[J]. 中国药物警戒, 2022, 19(12): 1344-1351.